Akoya Biosciences, Inc. (18)

Browse by Contract Category

Contracts

Offer Letter, dated March 2, 2021, including a Letter Amendment dated March 16, 2021, by and (Filed With SEC on April 12, 2021)
Akoya Biosciences, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on April 12, 2021)
Akoya Biosciences, Inc. 2021 Equity Incentive Plan and form of stock option agreement thereunder (Filed With SEC on April 12, 2021)
Exclusive Patent License Agreement, dated June 26, 2018, by and between the Registrant and the University of Washington (Filed With SEC on March 26, 2021)
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 26, 2021)
Form of Underwriting Agreement (Filed With SEC on April 12, 2021)
Offer Letter, dated March 2, 2021, by and between Registrant and Frederic Pla (Filed With SEC on March 26, 2021)
Amended and Restated Investors Rights Agreement, dated September 27, 2019, by and among the Registrant and certain of its stockholders (Filed With SEC on March 26, 2021)
Credit and Security Agreement, dated October 27, 2020, by and between the Registrant and Midcap Financial Trust (Filed With SEC on March 26, 2021)
Akoya Biosciences, Inc. 2015 Equity Incentive Plan, as amended, and form of stock option agreement thereunder (Filed With SEC on March 26, 2021)
License and Royalty Agreement, dated September 28, 2018, by and among the Registrant, PerkinElmer Health Sciences, Inc., Cambridge Research & Instrumentation, Inc. and VisEn... (Filed With SEC on March 26, 2021)
Amendment No. 1 to the License Agreement, dated November 18, 2016, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on March 26, 2021)
Exclusivity (Equity) Agreement, dated November 17, 2015, by and between the Registrant and The Board of Trustees of the Leland Stanford Junior University (Filed With SEC on March 26, 2021)
Offer Letter, dated July 14, 2020, by and between the Registrant and Niroshan Ramachandran (Filed With SEC on March 26, 2021)
Offer Letter, dated January 28, 2019, by and between the Registrant and Joseph Driscoll (Filed With SEC on March 26, 2021)
Letter Amendment, dated October 8, 2018, by and between the Registrant and Brian McKelligon (Filed With SEC on March 26, 2021)
Offer Letter, dated June 28, 2017, by and between the Registrant and Brian McKelligon (Filed With SEC on March 26, 2021)
Transition Services Agreement, dated September 28, 2018, by and between the Registrant and PerkinElmer Health Sciences, Inc., as amended by First Amendment to the Transition... (Filed With SEC on March 26, 2021)